On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics

Franz H Messerli^{1

2

3}, Chirag Bavishi⁴, Adrian W Messerli⁵, George C M Siontis¹

Affiliations

¹ Department of Cardiology, Bern University Hospital, University of Bern, Switzerland.
² Jagiellonian University, Krakow, Poland.
³ Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NU, USA.
⁴ Lifespan Cardiovascular Institute, Warren Alpert Medical School at Brown University, Providence, RI, USA.
⁵ Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.

Editorial

Franz H Messerli et al. Eur Heart J. 2021.

. 2021 Feb 14;42(7):758-760.

doi: 10.1093/eurheartj/ehaa971.

Franz H Messerli^{1

2

3}, Chirag Bavishi⁴, Adrian W Messerli⁵, George C M Siontis¹

¹ Department of Cardiology, Bern University Hospital, University of Bern, Switzerland.
² Jagiellonian University, Krakow, Poland.
³ Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NU, USA.
⁴ Lifespan Cardiovascular Institute, Warren Alpert Medical School at Brown University, Providence, RI, USA.
⁵ Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.

No abstract available

Comment in

Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.
Messerli FH, Bavishi C, Messerli AW, Siontis GCM. Messerli FH, et al. Eur Heart J. 2021 Nov 1;42(41):4282. doi: 10.1093/eurheartj/ehab567. Eur Heart J. 2021. PMID: 34480536 No abstract available.
Big cohort studies offer insights into preventable risk factors.
Wartolowska KA, Webb AJS. Wartolowska KA, et al. Eur Heart J. 2021 Nov 1;42(41):4280-4281. doi: 10.1093/eurheartj/ehab566. Eur Heart J. 2021. PMID: 34480539 Free PMC article. No abstract available.
How to identify which patients should not have a systolic blood pressure target of <120 mmHg.
Spence JD, Müller LO, Blanco PJ. Spence JD, et al. Eur Heart J. 2022 Feb 10;43(6):538-539. doi: 10.1093/eurheartj/ehab552. Eur Heart J. 2022. PMID: 34508627 No abstract available.
Importance of pulse pressure at low systolic blood pressure.
Messerli FH, Siontis GCM, Bavishi C, Messerli AW. Messerli FH, et al. Eur Heart J. 2022 Feb 10;43(6):540. doi: 10.1093/eurheartj/ehab553. Eur Heart J. 2022. PMID: 34508628 No abstract available.

Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
Wartolowska KA, Webb AJS. Wartolowska KA, et al. Eur Heart J. 2021 Feb 14;42(7):750-757. doi: 10.1093/eurheartj/ehaa756. Eur Heart J. 2021. PMID: 33238300 Free PMC article.